Ibrutinib-MPEA

Modify Date: 2024-01-08 19:03:22

Ibrutinib-MPEA structure	Common Name	Ibrutinib-MPEA
	CAS Number	1710768-30-1	Molecular Weight	581.71
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₂H₃₉N₉O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Ibrutinib-MPEA

Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1].

Name	Ibrutinib-MPEA

Description	Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
References	[1]. Liu N, et al. Direct and two-step bioorthogonal probes for Bruton's tyrosine kinase based on ibrutinib: a comparative study. Org Biomol Chem. 2015 May 14;13(18):5147-57.

Molecular Formula	C₃₂H₃₉N₉O₂
Molecular Weight	581.71